Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PPARG | P37231 | 19/20 | 0.82 |
| ▸ | PPARA | Q07869 | 19/20 | 0.82 |
| ▸ | PPARD | Q03181 | 4/20 | 0.82 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14848985 | 0.90 | PPARG (1.00) | PPARGPPARAPPARD | |
| SCHEMBL14841080 | 0.86 | PPARG (0.82) | PPARGPPARAPPARD | |
| SCHEMBL4889321 | 0.84 | PPARG (0.66) | PPARGPPARAPPARD | |
| SCHEMBL4680068 | 0.84 | PPARG (0.58) | PPARGPPARAPPARD | |
| SCHEMBL14841186 | 0.83 | PPARG (1.00) | PPARGPPARAPPARD | |
| SCHEMBL20235377 | 0.83 | PPARG (0.87) | PPARGPPARAPPARD | |
| SCHEMBL14848995 | 0.82 | PPARG (0.84) | PPARGPPARAPPARD | |
| SCHEMBL14849086 | 0.81 | PPARG (1.00) | PPARGPPARAPPARD | |
| SCHEMBL14848993 | 0.81 | PPARG (0.82) | PPARGPPARAPPARD | |
| SCHEMBL14851137 | 0.80 | PPARG (1.00) | PPARGPPARAPPARD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2018102399-A1 | METHODS OF DOSE ADMINISTRATION FOR TREATING OR PREVENTING COGNITIVE IMPAIRMENT USING INDANE ACETIC ACID DERIVATIVES | T3D THERAPEUTICS, INC. (US) | 2018-06-07 | — | — | WO | disclosed |
| WO-2018102358-A1 | METHODS OF TREATING OR PREVENTING COGNITIVE IMPAIRMENT USING INDANE ACETIC ACID DERIVATIVES BASED ON APOE4 GENOTYPE | T3D THERAPEUTICS, INC. (US) | 2018-06-07 | — | — | WO | disclosed |